Cite

HARVARD Citation

    Sugimoto, K. et al. (n.d.). Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast‐enhanced US. Liver international. pp. 605-615. [Online]. 
  
Back to record